Bombay Super Hybrid Seeds IPO vs Indo US Bio-Tech IPO
Comparison between Bombay Super Hybrid Seeds IPO and Indo US Bio-Tech IPO.
IPO Details
Bombay Super Hybrid Seeds IPO is a SME Fixed Price IPO proposed to list at NSE SME while Indo US Bio-Tech IPO is a SME Fixed Price proposed to list at BSE SME.
The total issue size of Bombay Super Hybrid Seeds IPO is up to ₹9.86 Cr whereas the issue size of the Indo US Bio-Tech IPO is up to ₹6.92 Cr. The final issue price of Bombay Super Hybrid Seeds IPO is ₹60.00 per share and of Indo US Bio-Tech IPO is ₹51.00 per share.
Bombay Super Hybrid Seeds IPO opens on Apr 12, 2018, while Indo US Bio-Tech IPO opens on Apr 30, 2018. The closing date of Bombay Super Hybrid Seeds IPO and Indo US Bio-Tech IPO is Apr 17, 2018, and May 03, 2018, respectively.
In the Bombay Super Hybrid Seeds IPO Retail Individual Investors (RII) are offered 8,22,000 shares while in Indo US Bio-Tech IPO retail investors are offered 8,22,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Bombay Super Hybrid Seeds IPO and 0 shares in Indo US Bio-Tech IPO.